Acute eosinophilic pneumonia associated with shock

Critical Care Medicine

Volumn 27, Issue 9, 1999, Pages 2014-2016

  Buddharaju, Venkata L ^a   Saraceno, Joseph L ^a,b   Rosen, Jonathan M ^a   Spivack, Simon D ^a   Smith, Thomas C ^a   Ilves, Riivo ^a   Killam, Donald A ^a   McKenna, Barbara J ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b Long Island Pulmonary Associates   (United States)

Author keywords

Eosinophilic; Interleukins; Pneumonia; Shock

Indexed keywords

COTRIMOXAZOLE; ERYTHROMYCIN; LEVOFLOXACIN; PREDNISONE;

ADULT; ARTICLE; CARDIOPULMONARY INSUFFICIENCY; CASE REPORT; CLINICAL FEATURE; HISTOPATHOLOGY; HUMAN; INTENSIVE CARE; LOEFFLER PNEUMONIA; LUNG BIOPSY; MALE; PATHOGENESIS; PRIORITY JOURNAL; SHOCK; THORAX RADIOGRAPHY;

ACUTE DISEASE; ADULT; BRONCHOALVEOLAR LAVAGE FLUID; HUMANS; MALE; PULMONARY EOSINOPHILIA; RESPIRATORY INSUFFICIENCY; SHOCK;

EID: 0032884999     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199909000-00048     Document Type: Article

References (13)

1. 1. Badesch DB, King TE, Schwartz MI: Acute eosinophilic pneumonia: A hypersensitivity phenomenon? Am Rev Respir Dis 1989; 139: 249-252
2. 2. Allen JN, Pacht ER, Gadek JE, et al: Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure. N Engl J Med 1989; 321:569-574
3. 3. Allen JN, Davis WB. Eosinophilic lung disease: State of the art. Am J Respir Crit Care Med 1994; 150:1423-1438
4. 4. Allen JN, Liao Z, Wewers MD, et al: Detection of IL-5 and IL-1 receptor antagonist in bronchoalveolar lavage fluid in acute eosinophilic pneumonia. J Allergy Clin Immunol 1996; 97:1366-1374
5. 5. Kawaguchi H, Yasuba H, Yamashita K, et al: A case of acute eosinophilic pneumonia: Bronchoalveolar lavage findings before and after steroid treatment [in Japanese]. Nihon Kyobu Shikkan Gakkai Zasshi 1995; 33: 738-744
6. 6. Yamaguchi S, Okubo Y, Hossain M, et al: IL-5 predominant in bronchoalveolar lavage fluid and peripheral blood with acute eosinophilic pneumonia. Intern Med 1995; 34:65-68
7. 7. Fisher CJ Jr, Dhainaut JF, Opal SM et al: Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: Results from a randomized, double-blind, placebo-controlled trial. JAMA 1994; 271:1836-1843
8. 8. Pugin J, Ricou B, Steinberg KP, et al: Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1β. Am J Respir Crit Care Med 1996; 153:1850-1856
9. 9. Miyazaki E, Sugisaki K, Shigenaga T, et al: A case of acute eosinophilic pneumonia caused by inhalation of Trichosporon terrestre. Am J Respir Crit Care Med 1995; 151:541-543
10. 10. Salerno SM, Strong JS, Roth BJ, et al: Eosinophilic pneumonia and respiratory failure associated with a trazodone overdose. Am J Respir Crit Care Med 1995; 152:2170-2172
11. 11. Seebach J, Speich R, Fehr J, et al: GM-CSF induced acute eosinophilic pneumonia. Br J Haematol 1995; 90:963-965
12. 12. Imokawa S, Sato A, Hayakawa H, et al: Possible involvement of an environmental agent in the development of acute eosinophilic pneumonia. Ann Allergy Asthma Immunol 1996; 76:419-422
13. 13. Tazelaar HD, Linz LJ, Colby TV, et al: Acute eosinophilic pneumonia: Histopathologic findings in nine patients. Am J Respir Crit Care Med 1997; 155:296-302